Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor

Naoki Kubo, Taishi Harada, Satoshi Anai, Kohei Otsubo, Yasuto Yoneshima, Kayo Ijichi, Takaomi Koga, Koichi Takayama, Yoichi Nakanishi

研究成果: Contribution to journalArticle査読

14 被引用数 (Scopus)

抄録

A 26-year-old man with unresectable inflammatory myofibroblastic tumor (IMT) presented with multiple metastases in the thoracic vertebra and lymph nodes as detected by positron emission tomography (PET) received chemotherapy with carboplatin plus paclitaxel. After three cycles of chemotherapy, fluorine-18-fluorodeoxyglucose (FDG)-PET/CT revealed tumor regression and significant reduction of FDG uptake in all lesions. The patient received six cycles of chemotherapy without any severe adverse event, and there was no sign of disease progression for seven months. This regimen is well tolerated and may be considered the treatment of choice for unresectable IMT.

本文言語英語
ページ(範囲)2399-2401
ページ数3
ジャーナルInternal Medicine
51
17
DOI
出版ステータス出版済み - 2012

All Science Journal Classification (ASJC) codes

  • Internal Medicine

フィンガープリント 「Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル